Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug prices on behalf of insurers, claiming they are illegally maximizing profits by steering patients to high-cost insulin products.
Express Scripts sues FTC over report blaming pharmacy middlemen for high drug costs
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” Express Scripts claims in the lawsuit that the report “is seventy-four pages of unsupported innuendo” leveled against it and other PBMs.
Market is Growing at CAGR of 6.0%, Increasing Demand for Cost-Effective Drug Management Solutions Propels Market Growth.Pune, ...
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
2025 and 2026, they're right around the corner, and many employers are making changes now for 2025 or are anticipating ...
As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...
A new Idaho law that goes into effect in January reforms pharmacy benefit managers to increase transparency and cut ...
Senior Life Pharmacy's mission is to enhance the health and independence of seniors by providing personalized, technology-driven pharmaceutical care. By offering services that make medication ...
Lastly, the Pharmacy benefit services represent around 30% of total revenue ... During the earnings call, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback